Levosimendan - Tenax Therapeutics

Home
About
Products
- TNX-201 (oral enteric coated imatinib)
- TNX-103 (oral levosimendan)
Education Center
Investors/Media
Contact

Search for:

Home
About
Products
- TNX-201 (oral enteric coated imatinib)
- TNX-103 (oral levosimendan)
Education Center
Investors/Media
Contact

Home
About
Products
- TNX-201 (oral enteric coated imatinib)
- TNX-103 (oral levosimendan)
Education Center
Investors/Media
Contact

Products
- TNX-201 (oral enteric coated imatinib)
- TNX-103 (oral levosimendan)
Education Center
Contact
- Email

Tenax Therapeutics

A Phase 3, development-stage pharmaceutical company focused on developing and commercializing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with a current focus on pulmonary hypertension.

Privacy Policy
Terms of Service